Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
US Department of Justice
Dow
McKinsey
Fuji
Harvard Business School
Moodys
Medtronic
Farmers Insurance

Generated: November 12, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020913

« Back to Dashboard

NDA 020913 describes AGGRASTAT, which is a drug marketed by Medicure and is included in two NDAs. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the AGGRASTAT profile page.

The generic ingredient in AGGRASTAT is tirofiban hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the tirofiban hydrochloride profile page.
Summary for 020913
Tradename:AGGRASTAT
Applicant:Medicure
Ingredient:tirofiban hydrochloride
Patents:2
Formulation / Manufacturing:see details
Generic Entry Opportunity Date for 020913
Generic Entry Date for 020913*:
Constraining patent/regulatory exclusivity:
Dosage:
INJECTABLE;INJECTION

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for NDA: 020913
Physiological EffectDecreased Platelet Aggregation
Suppliers and Packaging for NDA: 020913
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AGGRASTAT tirofiban hydrochloride INJECTABLE;INJECTION 020913 NDA Medicure International Inc 25208-002 25208-002-02 1 CONTAINER in 1 CARTON (25208-002-02) > 250 mL in 1 CONTAINER
AGGRASTAT tirofiban hydrochloride INJECTABLE;INJECTION 020913 NDA Medicure International Inc 25208-002 25208-002-03 1 VIAL, GLASS in 1 CARTON (25208-002-03) > 100 mL in 1 VIAL, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 25MG BASE/500ML (EQ 0.05MG BASE/ML)
Approval Date:May 14, 1998TE:RLD:No
Patent:➤ Sign UpPatent Expiration:Jan 29, 2019Product Flag?Substance Flag?Delist Request?
Patent:➤ Sign UpPatent Expiration:May 1, 2023Product Flag?Substance Flag?Delist Request?
Patented Use:A DOSING REGIMEN OF AGGRASTAT (TIROFIBAN HYDROCHLORIDE)(25MCG/KG FOLLOWED BY 0.15MCG/KG/MIN INFUSION) TO REDUCE THE RATE OF THROMBOTIC CORONARY EVENTS ASSOCIATED WITH ACUTE CORONARY SYNDROME (ACS) IN PATIENTS WITH NON-ST ELEVATION ACS

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 5MG BASE/100ML (EQ 0.05MG BASE/ML)
Approval Date:May 17, 2002TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Jan 29, 2019Product Flag?Substance Flag?Delist Request?

Expired US Patents for NDA 020913

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medicure AGGRASTAT tirofiban hydrochloride INJECTABLE;INJECTION 020913-002 May 17, 2002 ➤ Sign Up ➤ Sign Up
Medicure AGGRASTAT tirofiban hydrochloride INJECTABLE;INJECTION 020913-001 May 14, 1998 ➤ Sign Up ➤ Sign Up
Medicure AGGRASTAT tirofiban hydrochloride INJECTABLE;INJECTION 020913-003 Apr 20, 2000 ➤ Sign Up ➤ Sign Up
Medicure AGGRASTAT tirofiban hydrochloride INJECTABLE;INJECTION 020913-001 May 14, 1998 ➤ Sign Up ➤ Sign Up
Medicure AGGRASTAT tirofiban hydrochloride INJECTABLE;INJECTION 020913-002 May 17, 2002 ➤ Sign Up ➤ Sign Up
Medicure AGGRASTAT tirofiban hydrochloride INJECTABLE;INJECTION 020913-002 May 17, 2002 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
AstraZeneca
Healthtrust
Citi
Cipla
Boehringer Ingelheim
Farmers Insurance
Fish and Richardson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.